CorMedix Inc. (CRMD)
NASDAQ: CRMD · Real-Time Price · USD
6.48
+0.01 (0.23%)
Mar 9, 2026, 3:22 PM EDT - Market open
CorMedix Employees
As of December 31, 2024, CorMedix had 65 total employees, including 64 full-time and 1 part-time employees. The number of employees decreased by 18 or -21.69% compared to the previous year.
Employees
65
Change (1Y)
-18
Growth (1Y)
-21.69%
Revenue / Employee
$4,795,523
Profits / Employee
$2,493,338
Market Cap
511.85M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| ADC Therapeutics | 265 |
| Allogene Therapeutics | 229 |
| Prothena Corporation | 163 |
| Invivyd | 100 |
| Solid Biosciences | 100 |
| Neumora Therapeutics | 95 |
| Ocugen | 95 |
| Lexeo Therapeutics | 61 |
CRMD News
- 3 days ago - CorMedix Inc. (CRMD) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 4 days ago - CorMedix stock drops after earnings: is this dip a buy before key catalyst? - Invezz
- 4 days ago - CorMedix Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 7 days ago - CorMedix Inc. to Report Fourth Quarter and Full Year 2025 Financial Results and Provide a Corporate Update on March 5, 2026 - GlobeNewsWire
- 23 days ago - CorMedix Inc. (CRMD) Analyst/Investor Day Transcript - Seeking Alpha
- 25 days ago - CorMedix to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 5 weeks ago - CorMedix Therapeutics Announces Share Repurchase Program - GlobeNewsWire
- 5 weeks ago - CorMedix Therapeutics to Host In-Person and Virtual Analyst Day in New York on February 10, 2026 - GlobeNewsWire